All News

In the final part of our interview with Mark Garofoli, PharmD, BCGP, CPE, CTTS, he discusses what the future will hold regarding clinical decision-making following the reported acetaminophen-autism link.

Pharmacists are on the front line for patients looking to self-manage their menstrual pain, making their role invaluable in women’s health.

Pain medication expert Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to explore the referenced studies in the Trump Administration’s push to link acetaminophen use with autism.

Amid the prominent use of vaping in today’s society, researchers assess how it impacts pregnancy outcomes, including preterm birth, low birth weight, and small for gestational age.

The study results highlight the importance of pneumococcal vaccination for patients with chronic respiratory diseases, particularly chronic obstructive pulmonary disease.

Investigators examine the effects of combination therapy with metformin combined with sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, or thiazolidinediones.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, also known as “the Pain Guy,” discusses his initial reactions upon learning about the Trump Administration linking acetaminophen use with autism.

Further, after the introduction of the pneumococcal conjugate vaccine 10, investigators note a decrease of infections caused by multidrug resistance infection.

In part 3 of our interview with Rae McMahan, she explores her role at Prescryptive Health and how she’s helping pharmacy stakeholders navigate complex GLP-1 prescription drug benefits.

Along with the Senior Care Pharmacy Coalition, 3 additional long-term care advocacy groups have joined in on calls to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.

As part of this announcement, the administration launches initiatives across the National Institutes of Health, the FDA, and the Center for Medicare & Medicaid Services.

Through her work as senior vice president of payor solutions at Prescryptive Health, Rae McMahan shares insights into how increased GLP-1 popularity and costs impact pharmacies.

As their scope of practice continues to expand, researchers issue a survey on how community pharmacists conduct point-of-care testing for acute upper respiratory tract infections.

The vote for state and local jurisdictions requiring a prescription for administration of COVID-19 vaccines failed after a tiebreaker vote from the committee chair.

Rae McMahan, senior vice president of payor solutions at Prescryptive Health, discusses GLP-1 access, advertising, and the challenges that often accompany this drug class.

The clinical impact of sodium-glucose cotransporter 2 inhibitors on adults with type 2 diabetes calls for further research on the risk factors of treatment failure and patients’ economic outcomes.

Bumetanide nasal spray is available in 0.5 mg, which is an alternative to traditional oral and intravenous formulations for outpatient therapies.

FDA approves ruxolitinib cream for children with atopic dermatitis, offering a new nonsteroidal treatment option for better symptom management.

This year’s event, from October 18-21, 2025, will take place in New Orleans, Louisiana, at the Ernest N. Morial Convention Center.

The recommendations are provided through the West Coast Health Alliance and pull from guidance from the American Academy of Pediatrics and other organizations.

Hyperkalemia, chronic kidney disease, and hypertension often don’t manifest until the diseases become chronically uncontrolled, according to Ralph J. Riello III, PharmD, BCPS.

In an exploration of cardiovascular outcomes, health care utilization, and patient costs, researchers compare glucagon-like peptide-1s with alternative noninsulin glucose-lowering therapies.

The FDA also grants the biosimilar provisional interchangeability designation, making the drug substitutable at the pharmacy level.

In part 3 of our interview with Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, he discusses the ways in which his company is helping patients stay adherent on their medications.

Pharmacists enhance menstrual pain management by integrating holistic strategies, empowering women with personalized care and evidence-based guidance for better health outcomes.

Joanna Lewis, PharmD, MBA, discusses effective strategies for managing menstrual pain, including nonsteroidal anti-inflammatory drugs and supplements to enhance comfort and quality of life.

Among adults with type 1 diabetes, researchers explore how additional autoimmune diseases impacted patients’ physical and mental health burdens.

Approximately half of patients achieved a 50% or greater reduction from baseline monthly migraine days and sustained the response.